NCT07312123

Brief Summary

Carpal Tunnel Syndrome (CTS) is a common condition that causes numbness, tingling, pain, and weakness in the hand due to compression of the median nerve at the wrist. It can affect daily activities, work performance, and quality of life. While surgery is effective in severe cases, many patients with mild to moderate CTS are initially treated with non-surgical options such as splinting and medications. However, the effectiveness of oral supplements for CTS remains uncertain. This clinical study aims to evaluate whether an oral combination of alpha-lipoic acid, Vitamin E, and Vitamin B complex can safely reduce symptoms and improve hand function in patients with Carpal Tunnel Syndrome. These supplements are believed to have antioxidant, anti-inflammatory, and nerve-protective properties, which may help reduce nerve irritation and improve nerve recovery. Participants in this study will be randomly assigned to receive either the oral supplement combination or a comparator treatment. The study is single-blinded, meaning participants will not know which treatment they are receiving. Symptoms such as pain, numbness, and hand function will be assessed over a defined follow-up period using clinical evaluation and standardized questionnaires. The main hypothesis of this study is that patients receiving the oral combination of alpha-lipoic acid, Vitamin E, and Vitamin B will experience greater improvement in symptoms and functional outcomes compared to those who do not receive the combination, without significant side effects. The results of this study may help determine whether this oral supplement combination can be used as an effective and safe conservative treatment option for patients with Carpal Tunnel Syndrome, potentially reducing the need for invasive procedures.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Dec 2025Jan 2027

Study Start

First participant enrolled

December 8, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

December 16, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 31, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

December 16, 2025

Last Update Submit

April 20, 2026

Conditions

Keywords

carpal tunnel syndromemedian nerve compressionvitamin eperipheral nerve entrapment

Outcome Measures

Primary Outcomes (1)

  • Change in Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) score

    The Boston Carpal Tunnel Questionnaire (BCTQ) is a patient-reported tool used to assess symptom severity and functional status in carpal tunnel syndrome. It consists of two subscales, with each item scored from 1 (no symptoms or difficulty) to 5 (most severe symptoms or inability). The final score is calculated as the mean of responses, ranging from 1 to 5. Lower scores indicate better outcomes, while higher scores indicate more severe symptoms and functional impairment.

    Baseline to 12 and 24 weeks

Secondary Outcomes (1)

  • Change in Pain Intensity Measured by Visual Analog Scale

    Baseline to 12 and 24 weeks

Study Arms (2)

Oral Antioxidant Supplement Group

EXPERIMENTAL
Dietary Supplement: Alpha-Lipoic Acid, Vitamin E, and Vitamin B Complex

Control Group

ACTIVE COMPARATOR
Dietary Supplement: Combination Vitamin B1,B6,B12

Interventions

An oral dietary supplement containing a combination of alpha-lipoic acid, Vitamin E, and Vitamin B complex administered once daily for the study duration. The supplement is provided in capsule form and is intended to support nerve health through antioxidant and neuroprotective effects in patients with Carpal Tunnel Syndrome.

Oral Antioxidant Supplement Group

An oral Vitamin B complex supplement administered once daily for the study duration. This intervention serves as the active comparator for conservative treatment of Carpal Tunnel Syndrome.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age more than 18 years old
  • Subjects with symptoms and physical examination of CTS
  • Patients with CTS going for CT release

You may not qualify if:

  • Pregnant or breast-feeding women
  • Patients with history of trauma in the dominant hand

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Pakar Universiti Sains Malaysia

Kubang Kerian, Kelantan, 16150, Malaysia

RECRUITING

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Interventions

Thioctic AcidVitamin EVitamin B Complex

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Intervention Hierarchy (Ancestors)

Carboxylic AcidsOrganic ChemicalsThiophenesSulfur CompoundsCoenzymesEnzymes and CoenzymesFatty AcidsLipidsBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingVitaminsMicronutrientsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and Uses

Study Officials

  • nurhakim bin ibrahim

    Hospital Pakar Universiti Sains Malaysia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nurhakim Bin Ibrahim, MBBCH

CONTACT

ASSOCIATE PROFESSOR ABDUL NAWFAR BIN SADAGATULLAH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Officer, Master Student in Orthopedic

Study Record Dates

First Submitted

December 16, 2025

First Posted

December 31, 2025

Study Start

December 8, 2025

Primary Completion (Estimated)

December 8, 2026

Study Completion (Estimated)

January 31, 2027

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations